The severe asthma landscape is rapidly changing, as more precise phenotyping and new targeted therapies are introduced into practice. This course will address these new approaches and will focus on translation of new evidence into practice. This workshop will provide detailed and practical information about how to clinically assess individuals with severe asthma, and of the new treatment options available for disease management. Topics will include assessment (focused on vocal cord dysfunction and biomarkers), targeted therapies for treatment, disease registries and case studies. It will be relevant to a wide range of professionals including physicians and trainees, nurses, allied health professional and researchers. The programme will enhance clinicians’ practice and enable delivery of the latest evidenced-based health care to improve outcomes for this patient group.
Participants will develop an understanding of the important components to be included in a multidimensional assessment of individuals with severe asthma, and how to implement these assessments into practice.
Participants will gain a greater understanding of the comorbidities and risk factors affecting individuals with severe asthma, and will be familiar with treatment interventions.
Participants will become better equipped in selecting the most appropriate patients to trial new and targeted therapies in, and will be aware of the processes for commencing and evaluating therapies.
Participants will have an understanding of the benefits of disease registers for clinical practice and research, and will be aware of the disease registers current used in severe asthma.